CLEO DIAGNOSTICS LTD

Highlights Cleo Diagnostics Ltd

Equities

COV

AU0000288045

Delayed Australian S.E. Other stock markets 09:37:02 31/05/2024 am IST			5-day change	1st Jan Change
0.245 ^AUD	+6.52%		+44.12%	+40.00%

29/05	Study Finds Cleo Diagnostics ' Blood Test Outperforms Clinical Benchmarks	MT
11/04	Cleo Diagnostics Taps Lindus Health to Manage US Ovarian Cancer Clinical Trials	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Study Finds Cleo Diagnostics ' Blood Test Outperforms Clinical Benchmarks	29/05	MT
Cleo Diagnostics Taps Lindus Health to Manage US Ovarian Cancer Clinical Trials	11/04	MT
CLEO Taps HcFocus for US Market Entry	02/04	MT
Cleo Diagnostics Concludes Design Transfer of Ovarian Cancer Detection Test Technology	12/02	MT
Cleo Diagnostics Advances Development of Cancer Test Kit	09/23/09	MT
CLEO Diagnostics Secures US Patent for Ovarian Cancer Biomarker Testing	22/23/22	MT
Cleo Diagnostics Ltd has completed an IPO in the amount of AUD 12 million.	18/23/18	CI
Cleo Diagnostics Ltd has filed an IPO in the amount of AUD 12 million.	23/23/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer